Prevention and regression of carotid artery IMT with Cilostazol and Pioglitazone use in atherosclerosis with type 2 diabetes

Not Applicable

• Conditions: type 2 diabetes

• Registration Number: JPRN-UMIN000001729
• Lead Sponsor: CHIBAKEN SAISEIKAI NARASINO HOSPITAL internal medicine

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2009-03-01
• Study Completion: 2013-12-01
• Last Update Posted: 17 October 2023

Recruitment & Eligibility

• Sex: All
• Target Recruitment: 400

Inclusion Criteria

Not provided

Exclusion Criteria

1. HbA1c and over 10% 2. Medical history or presumptive of carotid arterial reconstruction 3. BNP and over 100 4. Early stage of stroke 5. Arterial fibrillation 6. Under anti-platelet therapy other than aspirin 7. Receiving warfarin-potassium therapy 8. Congestive heart failure 9. Severe hepatic disfunction or renal disfunction 10. Severe infections disease, injury, pre or post operation 11. Severe ketosis, diabetic coma, type 1 diabetes mellitus 12. Pts who are bleeding 13. Drug allergies or medical history of hypersensitivity to the investigational drugs 14. Pregnant or lactating women, or women who wish to become pregnant 15. Others whom the investigator judges inappropriate as subjects for this study

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Absolute change of carotid Max-IMT